News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
BOAN BIOTECH (06955.HK) Plans to Repurchase Shares of Up to 200 Million
BOAN BIOTECH (06955.HK) announced that, pursuant to the general mandate to repurchase shares approved at the annual general meeting held on June 5, 2025, and any general mandate fo...
Reset
Send
The window will close in 5 seconds
BOAN BIOTECH (06955.HK) Plans to Repurchase Shares of Up to 200 Million
Close
Recommend
2
Positive
3
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

BOAN BIOTECH (06955.HK)  0.000 (0.000%)    Short selling $92.16K; Ratio 0.241%   announced that, pursuant to the general mandate to repurchase shares approved at the annual general meeting held on June 5, 2025, and any general mandate for share repurchase to be approved by shareholders at general meetings from time to time in the future, it intends to repurchase shares of the Company with an aggregate value of not more than 200 million on the open market from time to time. The Company will conduct the share repurchase in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. (ha/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-26 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.